INS and polycystic ovary syndrome: Translating these findings to humans, a randomized, double-blind, placebo-controlled trial involving 34 PCOS patients revealed that three-month resveratrol supplementation reduced fasting insulin (FINS) by 31.8% and improved the insulin sensitivity index (ISI) by 66.3% (21).